Trial
NCT00546455
A Randomized, Double-blind Study of the Effects of Fenretinide Administered in Subjects With Obesity
Phase IISUSPENDEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of California, San Diego
Collaborators
—
Condition
Obesity
Intervention
Fenretinide
Why stopped
This study was terminated due to expired drug with possibility of re-starting in the future.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-02-10